Time-course of antibody responses against Coxiella burnetii following acute Q fever

Epidemiology and Infection

Volumn 141, Issue 1, 2013, Pages 62-73

  Teunis, P F M ^a,b   Schimmer, B ^a   Notermans, D W ^a   Leenders, A C A P ^c   Wever, P C ^c   Kretzschmar, M E E ^a,d   Schneeberger, P M ^c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b EMORY UNIVERSITY   (United States)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Coxiella; mathematical modelling; Q fever; serology; statistics

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; COXIELLA BURNETII; DISEASE COURSE; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; Q FEVER; QUANTITATIVE ANALYSIS; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; BACTERIAL PROTEINS; CHILD; COHORT STUDIES; COXIELLA BURNETII; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MODELS, THEORETICAL; NETHERLANDS; Q FEVER; TIME FACTORS; YOUNG ADULT;

EID: 84870933227     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812000404     Document Type: Article

References (23)

1. Schimmer B, et al. Large ongoing Q fever outbreak in the south of The Netherlands. Eurosurveillance 2008; 13(31).
2. Schimmer B, et al. Sustained intensive transmission of Q fever in the south of The Netherlands. Eurosurveillance 2009; 14(9).
3. van der Hoek W, et al. Q fever in The Netherlands: An update on the epidemiology and control measures. Eurosurveillance 2010; 15(12).
4. Dijkstra F, et al. The 2007-2010 Q fever epidemic in The Netherlands: Characteristics of notified acute Q fever patients and the association with dairy goat farming. FEMS Immunology and Medical Microbiology 2012; 64: 3-12.
5. Dupont HT, Thirion X, Raoult D. Q fever serology: Cutoff determination for microimmunofluorescence. Clinical Diagnostics and Laboratory Immunology 1994; 1: 189-196. (Pubitemid 2057614)
6. Marrie TJ, de Carolis E. Seroepidemiology of Coxiella burnetii infection and its frequency as a cause of community-acquired pneumonia in Canada. Canadian Journal of Infectious Diseases 2002; 13: 164-166. (Pubitemid 34855524)
7. Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. Journal of Clinical Microbiology 1998; 36: 1823-1834. (Pubitemid 28277760)
8. Schneeberger PM, et al. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clinical and Vaccine Immunology 2010; 17: 286-290.
9. Raoult D, Marrie TJ, Mege JL. Natural history and pathophysiology of Q fever. Lancet Infectious Diseases 2005; 5: 219-226. (Pubitemid 40410067)
10. Morroy G, et al. The health status of Q fever patients after long-term follow up. BMC Infectious Diseases 2011; 11: 97.
11. van der Hoek W, et al. Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clinical Infectious Diseases 2011; 52: 1431-1436.
12. Landais C, et al. From acute Q fever to endocarditis: Serological follow-up strategy. Clinical Infectious Diseases 2007; 44: 1337-1340. (Pubitemid 46717295)
13. Dupont HT, et al. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. American Journal of Medicine 1992; 93: 427-434.
14. Teunis PFM, et al. Kinetics of IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiology and Infection 2002; 129: 479-489. (Pubitemid 36157671)
15. Edelstein-Keshet L. Mathematical Models in Biology (Birkhauser Mathematics series). New York: McGraw-Hill Inc., 1988.
16. Simonsen J, et al. Estimation of incidences of infectious diseases based on antibody measurements. Statistics in Medicine 2009; 28: 1882-1885.
17. Teunis PFM, et al. Biomarker dynamics: Estimating infection rates from serological data. Statistics in Medicine (in press).
18. Teunis PFM, Ogden ID, Strachan NJC. Hierarchical dose response of E. coli O157:H7 from human outbreaks incorporating heterogeneity in exposure. Epidemiology and Infection 2008;136: 761-770. (Pubitemid 351524011)
19. Gilks WR, Richardson S, Spiegelhalter DJ (eds). Markov Chain Monte Carlo in Practice. London: Chapman & Hall, 1996.
20. Teunis PF, et al. Usefulness of sero-surveillance for Trichinella infections in animal populations. Veterinary Parasitology 2009; 159: 345-349.
21. Sunder S, et al. Chronic Q fever: Relevance of serology. Clinical Infectious Diseases 2011; 53: 749-750.
22. Limonard GJM, et al. One-year follow-up of patients of the ongoing Q fever outbreak: Clinical, serological and echocardiographic findings. Infection 2010; 38: 471-477.
23. Hung MN, et al. Serologic assessment of the risk of developing chronic Q fever in cohorts of acutely infected individuals. Journal of Infection 2011; 62: 39-44.